Cargando…
Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy
Oxidative stress plays a significant role in the pathogenesis of heart failure (HF). The aim of the study was to investigate the prognostic value of oxidation-reduction (redox) markers in patients with HF due to ischemic and nonischemic cardiomyopathy. The study included 707 patients of HF allocated...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062185/ https://www.ncbi.nlm.nih.gov/pubmed/33936385 http://dx.doi.org/10.1155/2021/6693405 |
_version_ | 1783681716919992320 |
---|---|
author | Wojciechowska, Celina Jacheć, Wojciech Romuk, Ewa Ciszek, Anna Bodnar, Patryk Chwalba, Tomasz Waliczek, Martyna Gąsior, Mariusz Rozentryt, Piotr |
author_facet | Wojciechowska, Celina Jacheć, Wojciech Romuk, Ewa Ciszek, Anna Bodnar, Patryk Chwalba, Tomasz Waliczek, Martyna Gąsior, Mariusz Rozentryt, Piotr |
author_sort | Wojciechowska, Celina |
collection | PubMed |
description | Oxidative stress plays a significant role in the pathogenesis of heart failure (HF). The aim of the study was to investigate the prognostic value of oxidation-reduction (redox) markers in patients with HF due to ischemic and nonischemic cardiomyopathy. The study included 707 patients of HF allocated into two groups depending on ethology: ischemic cardiomyopathy (ICM) (n = 435) and nonischemic cardiomyopathy (nICM) (n = 272), who were followed up for one year. The endpoint occurrence (mortality or heart transplantation) in a 1-year follow-up was similar in the ICM and nICM group. The predictive value of endpoint occurrence of oxidative stress biomarkers such as the serum protein sulfhydryl groups (PSH), malondialdehyde (MDA), uric acid (UA), bilirubin, and MDA/PSH ratio and other clinical and laboratory data were assessed in both groups (ICM and nICM) separately using univariate and multivariate Cox regression analyses. In multivariate analysis, the higher concentrations of UA (p = 0.015, HR = 1.024, 95% CI (1.005-1.044)) and MDA (p = 0.004, HR = 2.202, 95% CI (1.296-3.741)) were significantly associated with adverse prognosis in patients with ICM. Contrastingly, in patients with nICM, we observed that higher bilirubin concentration (p = 0.026, HR = 1.034, 95% CI (1.004-1.064)) and MDA/PSH ratio (p = 0.034, HR = 3.360, 95% CI (1.096-10.302)) were significantly associated with increased risk of death or HT. The results showed the association of different oxidative biomarkers on the unfavorable course of heart failure depending on etiology. |
format | Online Article Text |
id | pubmed-8062185 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-80621852021-04-29 Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy Wojciechowska, Celina Jacheć, Wojciech Romuk, Ewa Ciszek, Anna Bodnar, Patryk Chwalba, Tomasz Waliczek, Martyna Gąsior, Mariusz Rozentryt, Piotr Oxid Med Cell Longev Research Article Oxidative stress plays a significant role in the pathogenesis of heart failure (HF). The aim of the study was to investigate the prognostic value of oxidation-reduction (redox) markers in patients with HF due to ischemic and nonischemic cardiomyopathy. The study included 707 patients of HF allocated into two groups depending on ethology: ischemic cardiomyopathy (ICM) (n = 435) and nonischemic cardiomyopathy (nICM) (n = 272), who were followed up for one year. The endpoint occurrence (mortality or heart transplantation) in a 1-year follow-up was similar in the ICM and nICM group. The predictive value of endpoint occurrence of oxidative stress biomarkers such as the serum protein sulfhydryl groups (PSH), malondialdehyde (MDA), uric acid (UA), bilirubin, and MDA/PSH ratio and other clinical and laboratory data were assessed in both groups (ICM and nICM) separately using univariate and multivariate Cox regression analyses. In multivariate analysis, the higher concentrations of UA (p = 0.015, HR = 1.024, 95% CI (1.005-1.044)) and MDA (p = 0.004, HR = 2.202, 95% CI (1.296-3.741)) were significantly associated with adverse prognosis in patients with ICM. Contrastingly, in patients with nICM, we observed that higher bilirubin concentration (p = 0.026, HR = 1.034, 95% CI (1.004-1.064)) and MDA/PSH ratio (p = 0.034, HR = 3.360, 95% CI (1.096-10.302)) were significantly associated with increased risk of death or HT. The results showed the association of different oxidative biomarkers on the unfavorable course of heart failure depending on etiology. Hindawi 2021-04-15 /pmc/articles/PMC8062185/ /pubmed/33936385 http://dx.doi.org/10.1155/2021/6693405 Text en Copyright © 2021 Celina Wojciechowska et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Wojciechowska, Celina Jacheć, Wojciech Romuk, Ewa Ciszek, Anna Bodnar, Patryk Chwalba, Tomasz Waliczek, Martyna Gąsior, Mariusz Rozentryt, Piotr Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy |
title | Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy |
title_full | Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy |
title_fullStr | Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy |
title_full_unstemmed | Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy |
title_short | Serum Sulfhydryl Groups, Malondialdehyde, Uric Acid, and Bilirubin as Predictors of Adverse Outcome in Heart Failure Patients due to Ischemic or Nonischemic Cardiomyopathy |
title_sort | serum sulfhydryl groups, malondialdehyde, uric acid, and bilirubin as predictors of adverse outcome in heart failure patients due to ischemic or nonischemic cardiomyopathy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062185/ https://www.ncbi.nlm.nih.gov/pubmed/33936385 http://dx.doi.org/10.1155/2021/6693405 |
work_keys_str_mv | AT wojciechowskacelina serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT jachecwojciech serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT romukewa serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT ciszekanna serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT bodnarpatryk serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT chwalbatomasz serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT waliczekmartyna serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT gasiormariusz serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy AT rozentrytpiotr serumsulfhydrylgroupsmalondialdehydeuricacidandbilirubinaspredictorsofadverseoutcomeinheartfailurepatientsduetoischemicornonischemiccardiomyopathy |